Potential for cost economies in guiding therapy in patients with metastatic breast cancer

JFR Robertson; DK Whynes; A Dixon; RW Blamey

首页> 外文期刊>British Journal of Cancer >Potential for cost economies in guiding therapy in patients with metastatic breast cancer

【24h】

Potential for cost economies in guiding therapy in patients with metastatic breast cancer

机译：成本节约在转移性乳腺癌患者指导治疗中的潜力

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Therapeutic response in patients with advanced breast cancer is conventionally assessed with reference to criteria devised by the International Union Against Cancer. Evidence to date suggests, however, that assessments of equivalent quality may be obtained at lower cost from the use of serum markers. The paper presents estimates of potential cost savings resulting from the use of serum markers in place of conventional assessment and argues that the size of these savings merits the establishment of a randomised controlled trial.

机译：传统上，参照国际抗癌联盟制定的标准评估晚期乳腺癌患者的治疗反应。然而，迄今为止的证据表明，可以通过使用血清标志物以较低的成本获得同等质量的评估。本文介绍了使用血清标志物代替常规评估可能节省的费用，并认为节省的费用值得建立随机对照试验。

著录项

来源
《British Journal of Cancer》 |1995年第1期|共4页
作者
JFR Robertson; DK Whynes; A Dixon; RW Blamey;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Immunotherapy in the initial treatment of newly diagnosed cancer patients: utilization trend and cost projections for non-Hodgkin's lymphoma, metastatic breast cancer, and metastatic colorectal cancer. [J] . Shih YC, Elting LS, Pavluck A Cancer investigation . 2010,第1期

机译：新诊断癌症患者的初始治疗中的免疫治疗：非霍奇金淋巴瘤，转移性乳腺癌和转移性结直肠癌的利用趋势和费用预测。
2. Time-driven activity-based costing of a novel form of CT-guided high-dose-rate brachytherapy intraoperative radiation therapy compared with conventional breast intraoperative radiation therapy for early stage breast cancer [J] . Brachytherapy . 2020,第3期

机译：基于时间的活性的CT引导的高剂量速率逸出术中术中放射治疗的基于时间的耗时性与早期乳腺癌的常规乳房术中放射治疗相比
3. CONTESSA TRIO: A multinational, multicenter, phase 2 study of tesetaxel plus 3 different PD-(L)1 inhibitors in patients with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly patients with HER2-metastatic breast cancer (MBC) [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：Contessa Trio：跨国，多中心，第2期替补患者3种不同的PD-（L）1抑制剂在转移性三阴性乳腺癌（TNBC）和老年人患者中患者的胸膜肺癌（MBC）
4. Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase Ⅱ clinical trial [C] . Gabriela L. Ferrel, Feifan Zhou, Xiaosong Li, Biophotonics and immune responses IX . 2014

机译：Ⅱ期临床试验中激光免疫疗法对晚期转移性乳腺癌患者的影响
5. Boron Neutron Capture Therapy for HER2+ breast cancers: A feasibility study evaluating BNCT for potential role in breast conservation therapies. [D] . Jenkins, Peter Anthony. 2012

机译：HER2 +乳腺癌的硼中子捕获疗法：评估BNCT在乳腺癌保护疗法中潜在作用的可行性研究。
6. Potential for cost economies in guiding therapy in patients with metastatic breast cancer. [O] . J. F. Robertson, D. K. Whynes, A. Dixon, 1995

机译：成本经济在转移性乳腺癌患者中指导治疗的潜力。
7. Potential for cost economies in guiding therapy in patients with metastatic breast cancer. [O] . Robertson, J. F., Whynes, D. K., Dixon, A., 1995

机译：成本经济在转移性乳腺癌患者中指导治疗的潜力。
8. Novel Differentiation Therapy Approach to Reduce the Metastatic Potential of Basal, Highly Metastatic, Triple-Negative Breast Cancers. [R] . Chu, I. 2012

机译：新型分化治疗方法降低基底，高转移性，三阴性乳腺癌的转移潜能。

Potential for cost economies in guiding therapy in patients with metastatic breast cancer

摘要

著录项

相似文献

相关主题

期刊订阅